Today's Daily Dose brings you news about artificial ovary; FDA approval of Alkermes' INITIO; MabVax' decision regarding Delinquent Filing; Titan Pharma's decision to postpone enrollment in the second cohort of patients in its Phase 1/2 trial of Ropinirole and Merck's upcoming regulatory catalyst.
from RTT - Biotech https://ift.tt/2tXimqz
via IFTTT
No comments:
Post a Comment